INVESTOR ALERT REMINDER: The Schall Law Firm Announces the

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
18
INVESTOR ALERT REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Alkermes plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES, Feb. 04, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Alkermes plc (“Alkermes” or “the Company”) (NASDAQ: ALKS ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company's shares between February 17, 2017 and November 1, 2018, inclusive (the ''Class Period''), are encouraged to contact the firm before February 25, 2019.           

If you are a shareholder who suffered a loss, click here to participate .

We also encourage you to contact Brian Schall, or Sherin Mahdavian, of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at  www.schallfirm.com , or by email at  brian@schallfirm.com .

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Alkermes was advised by the FDA to use a specific protocol with its New Drug Application submission for ALKS 5461. The Company subsequently failed to follow the protocol. After reviewing the submission, an FDA advisory committee decided in a 21 to 2 vote against approving ALKS 5461. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Alkermes, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm Brian Schall, Esq., Sherin Mahdavian, Esq., www.schallfirm.com Office: 310-301-3335 Cell: 424-303-1964 info@schallfirm.com

SOURCE:

  The Schall Law Firm

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 4

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 5

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 6

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 1

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 3

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 3

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 6

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 2

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading

Top 5 Most Recently Viewed Articles

ANEW Medical Expands Portfolio with Needle-Free Technology

Updated Category News Views 79

ANEW Medical, Inc. Acquires Innovative Technology ANEW MEDICAL, INC. (“ANEW” or the “Company”) (Nasdaq: WENA) has announced that it has signed an exclusive worldwide licensing agreement with Transfertech Sherbrooke (“TTS”) for Nanoject. This innovative technology is a needle-free, freeze-dried nanopowder autoinjector designed for administering medicines and...

Continue Reading
Empire Media Worx Partners with Ultrack for Better Pets Brand Growth

Updated Category News Views 145

Ultrack Systems Inc. Engages Empire Media Worx for Better Pets Ultrack Systems Inc. (OTC: MJLB) is excited to announce a strategic partnership with Empire Media Worx Inc., aiming to revamp its Better Pets division. This creative collaboration marks a significant step for Ultrack, a technology firm actively involved in the pet wellness market. A Landmark Collaboration for...

Continue Reading
Key Highlights from the Recent Annual General Meeting

Updated Category News Views 338

Key Highlights from the Recent Annual General Meeting In a significant event for shareholders and stakeholders alike, the annual general meeting of Ringkjøbing Landbobank was held, where important decisions regarding the bank’s operations were discussed and voted upon. Many notable aspects were covered during this assembly, which marks a key moment in the bank's fiscal...

Continue Reading
AMD Forms Strategic Alliance with Absci for Healthcare AI Growth

Updated Category News Views 221

AMD Strengthens Its Position in AI Through Absci Investment Advanced Micro Devices (NASDAQ: AMD) has decided to invest $20 million in Absci, a drug-discovery company. This investment marks AMD's entry into the healthcare sector, focusing on the utilization of its advanced artificial intelligence (AI) chips. The aim is to enhance the capabilities of AI in the healthcare...

Continue Reading
Legacy Commercial Property's Strategic Retail Expansion in Alabama

Updated Category News Views 164

Legacy Commercial Property Expands Its Horizons Legacy Commercial Property has made an important move in the retail sector by acquiring the Hunnington Center, a significant retail plaza that spans 55,000 square feet. This new property is situated on Memorial Parkway, right in the heart of a rapidly growing area. It’s an exciting time for the company as they broaden...

Continue Reading